Company: BLUWU
Filing Date: 2025-03-31
Form Type: S-1/A
Source: 0001641172-25-001410
Chunk: 157

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-03-31
Form: S-1/A
Chunk 157
---
 a blank check company incorporated on November 1, 2024 as a Cayman Islands exempted company with no material operations of our own and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on high-potential companies in the biotechnology, healthcare and technology sectors. Our mission is to leverage our management team’s extensive expertise and deep industry connections to drive transformative advancements and generate substantial returns for our investors.

<div align='center'>Investment Focus</div>

We are strategically positioned to capitalize on the immense opportunities within the biotechnology, healthcare, and technology sectors. With a seasoned team, extensive industry experience, and a disciplined investment approach, we are committed to creating value for our investors while fostering the next generation of industry leaders.

Biotechnology and Healthcare

The biotechnology and healthcare sectors are experiencing rapid growth fueled by innovations in drug discovery, personalized medicine, medical devices, and telemedicine. We intend to target companies that are leading the charge in developing groundbreaking therapies, diagnostic tools, and health technology solutions. Key areas of focus include:

| ● | Pharmaceutical Development:                                                                                       
 We intend to seek investments in companies with promising drug pipelines aimed at addressing unmet medical needs. |

| ● | Medical Devices: Our                                                                                                               
 strategy includes supporting the development of advanced devices that enhance patient outcomes and streamline healthcare delivery. |

| ● | Telemedicine: We aim                                                                                  
 to enhance healthcare accessibility through digital health platforms and remote monitoring solutions. |

| ● | Health Tech Innovations:                                                                                              
 Our focus encompasses advancements in AI-driven diagnostics, wearable health technologies, and health data analytics. |

Technology

The technology sector remains a critical driver of economic growth and innovation. Our investment strategy is centered on companies that are revolutionizing industries through advanced technological solutions. Key areas of interest include:

| ● | Artificial Intelligence                                                                                                       
 and Machine Learning: We intend to invest in AI-driven companies that offer transformative solutions across multiple sectors. |

| ● | Cloud Computing: Our                                                                             
 focus includes businesses that provide scalable and efficient cloud infrastructure and services. |

| ● | Cybersecurity: We                                                                                                
 prioritize